Summary of Study ST003117

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001936. The data can be accessed directly via it's Project DOI: 10.21228/M8GB12 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003117
Study TitleMetabolomics of patients with Plasmodium vivax malaria
Study SummaryBackground: Malaria is the leading parasitic disease worldwide, with P. vivax being a major challenge for its control. Several studies have indicated metabolomics as a promising tool for combating the disease. Objective: The study evaluated plasma metabolomic profiles of patients with recurrent and non-recurrent P. vivax malaria in the Brazilian Amazon. Methods: Metabolites extracted from the plasma of P. vivax-infected patients were subjected to LC-MS analysis. Untargeted metabolomics was applied to investigate the metabolic profile of the plasma in the two groups. Results: Overall, 51 recurrent and 59 non-recurrent patients were included in the study. Longitudinal metabolomic analysis revealed 52 and 37 significant metabolite features from the recurrent and non-recurrent participants, respectively. Recurrence was associated with disturbances in eicosanoid metabolism. Comparison between groups suggest alterations in vitamin B6 (pyridoxine) metabolism, tyrosine metabolism, 3-oxo-10-octadecatrienoate β-oxidation, and alkaloid biosynthesis II. Integrative network analysis revealed enrichment of other metabolic pathways for the recurrent phenotype, including the butanoate metabolism, aspartate and asparagine metabolism, and N-glycan biosynthesis. Conclusion: The metabolites and metabolic pathways predicted in our study suggest potential biomarkers of recurrence and provide insights into targets for antimalarial development against P. vivax.
Institute
University of Sao Paulo
Last NameGardinassi
First NameLuiz Gustavo
AddressAv. dos Bandeirantes, 3900, Campus Universitário, Ribeirão Preto, SP, Brazil
Emailgardinassi@eerp.usp.br
Phone55 16 3315-3395
Submit Date2024-03-01
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2024-04-05
Release Version1
Luiz Gustavo Gardinassi Luiz Gustavo Gardinassi
https://dx.doi.org/10.21228/M8GB12
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Class Day Treatment Sample source
SA341187ID_22non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341188ID_295non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341189ID_298non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341190ID_82non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341191ID_40non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341192ID_179non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341193ID_300non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341194ID_25non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341195ID_224non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341196ID_61non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341197ID_216non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341198ID_212non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341199ID_250non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341200ID_164non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341201ID_95non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341202ID_278non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341203ID_110non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341204ID_318non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341205ID_5non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341206ID_118non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341207ID_112non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341208ID_266non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341209ID_103non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341210ID_230non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341211ID_145non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341212ID_138non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341213ID_130non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341214ID_151non-recurrence 0 CQ+PQDHA+PQ422 Plasma
SA341215ID_47non-recurrence 0 CQ+PQ Plasma
SA341216ID_173non-recurrence 0 CQ+PQ Plasma
SA341217ID_120non-recurrence 0 CQ+PQ Plasma
SA341218ID_106non-recurrence 0 CQ+PQ Plasma
SA341219ID_99non-recurrence 0 CQ+PQ Plasma
SA341220ID_76non-recurrence 0 CQ+PQ Plasma
SA341221ID_56non-recurrence 0 CQ+PQ Plasma
SA341222ID_313non-recurrence 0 CQ+PQ Plasma
SA341223ID_275non-recurrence 0 CQ+PQ Plasma
SA341224ID_281non-recurrence 0 CQ+PQ Plasma
SA341225ID_248non-recurrence 0 DHA+PQ42 Plasma
SA341226ID_287non-recurrence 0 DHA+PQ42 Plasma
SA341227ID_185non-recurrence 0 DHA+PQ42 Plasma
SA341228ID_234non-recurrence 0 DHA+PQ42 Plasma
SA341229ID_17non-recurrence 0 DHA+PQ42 Plasma
SA341230ID_156non-recurrence 0 DHA+PQ42 Plasma
SA341231ID_192non-recurrence 0 DHA+PQ42 Plasma
SA341232ID_270non-recurrence 0 DHA+PQ42 Plasma
SA341233ID_128non-recurrence 0 DHA+PQ42 Plasma
SA341234ID_289non-recurrence 0 DHA+PQ42 Plasma
SA341235ID_3non-recurrence 0 DHA+PQ42 Plasma
SA341236ID_260non-recurrence 0 DHA+PQ42 Plasma
SA341237ID_161non-recurrence 0 DHA+PQ Plasma
SA341238ID_34non-recurrence 0 DHA+PQ Plasma
SA341239ID_301non-recurrence 0 DHA+PQ Plasma
SA341240ID_206non-recurrence 0 DHA+PQ Plasma
SA341241ID_310non-recurrence 0 DHA+PQ Plasma
SA341242ID_123non-recurrence 0 DHA+PQ Plasma
SA341243ID_243non-recurrence 0 DHA+PQ Plasma
SA341244ID_303non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341245ID_188non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341246ID_77non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341247ID_307non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341248ID_105non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341249ID_317non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341250ID_7non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341251ID_12non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341252ID_142non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341253ID_88non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341254ID_154non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341255ID_150non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341256ID_165non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341257ID_199non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341258ID_242non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341259ID_238non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341260ID_283non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341261ID_33non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341262ID_258non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341263ID_43non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341264ID_263non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341265ID_286non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341266ID_54non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341267ID_220non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341268ID_65non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341269ID_210non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341270ID_28non-recurrence 6 CQ+PQDHA+PQ422 Plasma
SA341271ID_204non-recurrence 6 CQ+PQ Plasma
SA341272ID_207non-recurrence 6 CQ+PQ Plasma
SA341273ID_314non-recurrence 6 CQ+PQ Plasma
SA341274ID_309non-recurrence 6 CQ+PQ Plasma
SA341275ID_9non-recurrence 6 CQ+PQ Plasma
SA341276ID_38non-recurrence 6 CQ+PQ Plasma
SA341277ID_132non-recurrence 6 CQ+PQ Plasma
SA341278ID_229non-recurrence 6 CQ+PQ Plasma
SA341279ID_127non-recurrence 6 CQ+PQ Plasma
SA341280ID_321non-recurrence 6 CQ+PQ Plasma
SA341281ID_71non-recurrence 6 DHA+PQ42 Plasma
SA341282ID_195non-recurrence 6 DHA+PQ42 Plasma
SA341283ID_268non-recurrence 6 DHA+PQ42 Plasma
SA341284ID_280non-recurrence 6 DHA+PQ42 Plasma
SA341285ID_62non-recurrence 6 DHA+PQ42 Plasma
SA341286ID_172non-recurrence 6 DHA+PQ42 Plasma
Showing page 1 of 4     Results:    1  2  3  4  Next     Showing results 1 to 100 of 319
  logo